TABLE 3.
Neutralizing antibody IC50 titers against the wild-type and mutant clones with monoclonal antibodies targeting the V2, V3, and CD4bs regions
| Tier | Clone | IC50 (μg/ml) |
||
|---|---|---|---|---|
| V2 | V3 | CD4bs | ||
| 1 | wt | 0.045 | 0.016 | 0.028 |
| ΔCT | >50 | >50 | >50 | |
| 2 | wt | 5.260 | 0.065 | 0.160 |
| ΔCT | >50 | >50 | >50 | |
| 3 | wt | >50 | >50 | >50 |
| ΔCT | >50 | >50 | >50 | |